Together, these phenotypic changes suggest that impairment of TMEM135 function affects molecular pathways involved in the pathogenesis of metabolic disease with dysregulated lipid metabolism, which may include activation of PPAR signaling and increased peroxisome proliferation (34). This evidence concerns the gene TMEM135 and metabolic disease.